SIC 2835 – In Vitro and In Vivo Diagnostic Substances
Valuation | |
---|---|
Market Cap ($M) | 95.04 |
Enterprise Value ($M) | 81.64 |
Book Value ($M) | 10.28 |
Book Value / Share | 0.30 |
Price / Book | 9.25 |
NCAV ($M) | 7.92 |
NCAV / Share | 0.23 |
Price / NCAV | 12.00 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -2.28 |
Return on Assets (ROA) | -0.66 |
Return on Equity (ROE) | -0.93 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 3.51 |
Current Ratio | 3.51 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 25.00 |
Assets | 27.36 |
Liabilities | 17.08 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -39.07 |
Net Income | -39.83 |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -29.77 |
Cash from Investing | -21.58 |
Cash from Financing | 48.53 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Franklin Resources Inc | 12.60 | -23.34 | |
13G/A | Vanguard Group Inc | 4.95 | -11.51 | |
13G | BlackRock, Inc. | 6.00 | ||
13G/A | Contrarian Alpha, LP | 6.60 | 9.77 | |
13G | Propel Bio Management, LLC | 6.81 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
35,855 | 115,907 | 30.93 | |
44,865 | 117,124 | 38.31 | |
66,359 | 161,678 | 41.04 | |
32,170 | 110,321 | 29.16 | |
(click for more detail) |
Similar Companies | |
---|---|
ABEO – Abeona Therapeutics Inc. | ABVC – ABVC BioPharma, Inc. |
ACB – Aurora Cannabis Inc. | ACXP – Acurx Pharmaceuticals, Inc. |
ADIL – Adial Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io